Biological Immunology

Ocrevus

Payments companies reported to CMS as associated with Ocrevus. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$5.1Massociated payments (2023-2025)

5,286clinicians with associated payments

5companies reporting

By year

2023 $2.0M

2024 $1.6M

2025 $1.6M

Payments reported as associated with Ocrevus, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurology (Psychiatry & Neurology) $4.3M

Family $95K

Neuromuscular Medicine (Psychiatry & Neurology) $72K

Physician Assistant $63K

Nurse Practitioner $61K

Pediatrics $52K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Ocrevus

These are the largest totals companies reported as associated with Ocrevus. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Stephen Krieger	New York, NY	Neurology (Psychiatry & Neurology)	$131,082.42
Ann Bass	San Antonio, TX	Neurology (Psychiatry & Neurology)	$114,702.43
Amanda Hernandez-Jones	Farmington, CT	Neurology (Psychiatry & Neurology)	$113,184.42
Gabriel Pardo	Oklahoma City, OK	Neurology (Psychiatry & Neurology)	$113,122.82
Mitzi Williams	Smyrna, GA	Neurology (Psychiatry & Neurology)	$93,615.64
Barry Singer	Saint Louis, MO	Neurology (Psychiatry & Neurology)	$89,789.80
Robert Shin	Charlottesville, VA	Neurology (Psychiatry & Neurology)	$83,746.56
Tamara Miller	Fort Collins, CO		$70,197.29
Angel Chinea	Guaynabo, PR	Neurology (Psychiatry & Neurology)	$68,384.30
Mary Ann Picone	Teaneck, NJ	Neurology (Psychiatry & Neurology)	$64,954.35

Prescribed Ocrevus?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.